Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / ADSs
-
Shares outstanding
-
592,878
-
Total 13F shares
-
335,947
-
Share change
-
+81,948
-
Total reported value
-
$789,000
-
Price per share
-
$2.35
-
Number of holders
-
13
-
Value change
-
+$204,452
-
Number of buys
-
7
-
Number of sells
-
5
Institutional Holders of Scinai Immunotherapeutics Ltd. - ADSs (BVXV) as of Q4 2021
As of 31 Dec 2021 Scinai Immunotherapeutics Ltd. - ADSs (BVXV) had 13 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 335,947 shares of stock of the company.
Largest 10 holders included STATE STREET CORP, ENVESTNET ASSET MANAGEMENT INC, TWO SIGMA SECURITIES, LLC, TRUE Private Wealth Advisors, MORGAN STANLEY, ExodusPoint Capital Management, LP, GEODE CAPITAL MANAGEMENT, LLC, UBS Group AG, CREDIT AGRICOLE S A, and ROYAL BANK OF CANADA.
This table shows 13 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.